Genérico Cytoxan é usado para tratar certos tipos dos seguintes cancros: linfoma, mieloma múltiplo, leucemia, micose fungóide, neuroblastoma, cancro nos ovários, olhos e mama. É normalmente usado em combinação com outros medicamentos. Pode também ser usado para tratar alguns tipos de problemas nos rins (síndrome nefrótica) em crianças.
Cyclophosphamide drug makes the bone marrow more tumor-friendly - News-Medical.net
Cyclophosphamide drug makes the bone marrow more tumor-friendlyNews-Medical.
Docs Need Primer on Long-Term Effects of Chemotherapy - Family Practice News Digital Network
Family Practice News Digital NetworkDocs Need Primer on Long-Term Effects of ChemotherapyFamily Practice News Digital NetworkOnly 6% of primary care physicians were able to identify the main long-term effects (LEs) of doxorubicin (Adriamycin), paclitaxel (Taxol), oxaliplatin (Eloxatin), and cyclophosphamide (Cytoxan), compared with 65% of oncologists surveyed.
ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule ... - MarketWatch (press release)
ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule .
Clinical Conundrums - Clinical Oncology News
Clinical Oncology NewsClinical ConundrumsClinical Oncology NewsTrue or False: In the SWOG S0016/CALGB 50102 trial for patients with previously untreated FL, inferior outcomes were observed with maintenance rituximab versus tositumomab/ 131 I-tositumomab (CHOP-RIT; GlaxoSmithKline) following cyclophosphamide, .
Diffuse Large B-Cell Lymphoma: Current Treatment Approaches - Cancer Network
Diffuse Large B-Cell Lymphoma: Current Treatment ApproachesCancer NetworkWhile a series of trials support R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone, plus rituximab)-21 as the standard of care for all patients, DLBCL has substantial biological and clinical heterogeneity, leading to marked differences .